Olaplex Holdings Inc header image

Olaplex Holdings Inc

OLPX

Equity

ISIN null / Valor 113471584

NASDAQ (2025-11-21)
USD 1.10+6.80%

Olaplex Holdings Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Olaplex Holdings Inc is a science-enabled beauty company focused on improving the hair health of consumers through innovative technology. The company disrupted the professional hair care industry in 2014 by introducing bond building products that protect, strengthen, and rebuild broken bonds in the hair. With patent-protected ingredients that work on a molecular level to repair damage, Olaplex's award-winning products are distributed globally through various channels, including professional salons, specialty retailers, and direct-to-consumer platforms.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (15.10.2025):

Olaplex Holdings Inc reported its second quarter of 2025 results, showing a moderate increase in net sales but a shift to a net loss compared to the same period last year. The company is actively transforming its business strategy and remains optimistic about future growth through its Bonds and Beyond initiative.

Net Sales Increase

For the second quarter of 2025, Olaplex reported a 2.3% increase in net sales, reaching $106.3 million. In the United States, net sales grew by 2.5%, while internationally, sales rose by 1.9%. Among sales channels, Professional and Direct-To-Consumer segments saw significant growth of 12.1% and 12.8% respectively, whereas Specialty Retail declined by 16.7%.

Profitability Challenges

The company experienced a net loss of $7.7 million in the second quarter of 2025, compared to a net income of $5.8 million in the same quarter of 2024. Diluted earnings per share (EPS) also declined to ($0.01) from $0.01 year-over-year, indicating challenges in maintaining profitability.

Cost Management

Gross profit for the quarter increased by 4.4% to $75.6 million, with the gross profit margin improving slightly to 71.2%. However, selling, general, and administrative (SG&A) expenses surged by 45.1% to $65.9 million, significantly impacting overall profitability.

Fiscal Year 2025 Guidance

Olaplex has reiterated its fiscal year 2025 guidance, projecting net sales between $410 million and $431 million. The company expects an adjusted gross profit margin of 70.5% to 71.5% and an adjusted EBITDA margin of 20% to 22%. Management anticipates a high single-digit decline in net sales for the third quarter and a high single-digit increase in the fourth quarter compared to the prior year.

Summarized from source with an LLMView Source

Key figures

-45.0%1Y
-79.1%3Y
%5Y

Performance

63.3%1Y
69.6%3Y
80.5%5Y

Volatility

Market cap

734 M

Market cap (USD)

Daily traded volume (Shares)

1,394,110

Daily traded volume (Shares)

1 day high/low

1.75 / 1.67

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Edwards Lifesciences Corp
Edwards Lifesciences Corp Edwards Lifesciences Corp Valor: 1065343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.24%USD 85.13
Dyne Therapeutics Inc
Dyne Therapeutics Inc Dyne Therapeutics Inc Valor: 56806425
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.27%USD 21.18
Boiron SA
Boiron SA Boiron SA Valor: 487646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.95%EUR 26.60
Bright Horizons Family Solutions
Bright Horizons Family Solutions Bright Horizons Family Solutions Valor: 19920287
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.62%USD 101.12
Dr Reddy'S Laboratories Ltd
Dr Reddy'S Laboratories Ltd Dr Reddy'S Laboratories Ltd Valor: 1221723
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%USD 13.91
SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA SCHOTT Pharma AG & Co. KGaA Valor: 128964250
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.66%EUR 18.44
Coloplast A/S
Coloplast A/S Coloplast A/S Valor: 20259063
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.55%DKK 580.20
MannKind Corp
MannKind Corp MannKind Corp Valor: 35935511
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.21%USD 5.03
Essity AB
Essity AB Essity AB Valor: 36851944
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.79%SEK 260.90
Lifco Ab
Lifco Ab Lifco Ab Valor: 111355378
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.18%SEK 342.20